Nothing Special   »   [go: up one dir, main page]

DE69635708D1 - Tetrandrin zur behandlung von augenentzündungen - Google Patents

Tetrandrin zur behandlung von augenentzündungen

Info

Publication number
DE69635708D1
DE69635708D1 DE69635708T DE69635708T DE69635708D1 DE 69635708 D1 DE69635708 D1 DE 69635708D1 DE 69635708 T DE69635708 T DE 69635708T DE 69635708 T DE69635708 T DE 69635708T DE 69635708 D1 DE69635708 D1 DE 69635708D1
Authority
DE
Germany
Prior art keywords
tetrandrin
ignitions
eye
treatment
eye ignitions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635708T
Other languages
English (en)
Other versions
DE69635708T2 (de
Inventor
Shixing Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Eye and Ear
Original Assignee
Massachusetts Eye and Ear Infirmary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Eye and Ear Infirmary filed Critical Massachusetts Eye and Ear Infirmary
Application granted granted Critical
Publication of DE69635708D1 publication Critical patent/DE69635708D1/de
Publication of DE69635708T2 publication Critical patent/DE69635708T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69635708T 1995-04-11 1996-04-09 Tetrandrin zur behandlung von augenentzündungen Expired - Fee Related DE69635708T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US420244 1995-04-11
US08/420,244 US5627195A (en) 1995-04-11 1995-04-11 Treatment for ocular inflammation
PCT/US1996/006041 WO1996032108A1 (en) 1995-04-11 1996-04-09 Treatment for ocular inflammation

Publications (2)

Publication Number Publication Date
DE69635708D1 true DE69635708D1 (de) 2006-03-30
DE69635708T2 DE69635708T2 (de) 2006-08-24

Family

ID=23665669

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635708T Expired - Fee Related DE69635708T2 (de) 1995-04-11 1996-04-09 Tetrandrin zur behandlung von augenentzündungen

Country Status (8)

Country Link
US (1) US5627195A (de)
EP (1) EP0820286B1 (de)
JP (1) JPH11503736A (de)
CN (1) CN1148187C (de)
CA (1) CA2217599A1 (de)
DE (1) DE69635708T2 (de)
ES (1) ES2250990T3 (de)
WO (1) WO1996032108A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627195A (en) * 1995-04-11 1997-05-06 Massachusetts Eye And Ear Infirmary Treatment for ocular inflammation
US5891855A (en) * 1996-02-12 1999-04-06 The Scripps Research Institute Inhibitors of leaderless protein export
JPH11180873A (ja) * 1997-12-22 1999-07-06 Kaken Shoyaku Kk ＮＦ−κＢ活性阻害剤
US5908628A (en) * 1998-05-01 1999-06-01 Hou; Liping Compositions with analgesic, antipyretic and antiinflammatory properties
US6315996B1 (en) * 1999-04-09 2001-11-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Topical lysostaphin therapy for staphylococcus ocular infections
US6350476B1 (en) 2000-05-22 2002-02-26 Shanxi Zhengzhon Pharmaceutical Co., Ltd. Herbal chinese joint complex
CN1294911C (zh) * 2004-01-13 2007-01-17 胡世兴 汉防己甲素眼用制剂
US7799802B2 (en) * 2004-08-03 2010-09-21 Institstute of Oriental Medical Science Inc. Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
KR100861320B1 (ko) * 2007-05-30 2008-10-01 한국과학기술연구원 다우리놀을 유효성분으로 함유하는 암 예방 및 치료용약학적 조성물
CN101744817B (zh) * 2009-12-28 2012-09-05 南昌弘益科技有限公司 治疗角膜病的汉防己甲素
CN102266338A (zh) * 2010-06-01 2011-12-07 吉林大学 用于提高分支杆菌胞内药物浓度的外输蛋白抑制剂
US9040099B1 (en) 2010-11-02 2015-05-26 Seven Consulting, Inc. Botanical composition and method for treating pain and discomfort of various conditions
US8501248B1 (en) 2010-11-02 2013-08-06 Seven Consulting, Inc. Botanical composition and method for treating pain and discomfort of various conditions
CN105358149A (zh) * 2013-03-15 2016-02-24 Cba制药公司 粉防己碱家族的药物制剂和方法
WO2015026205A1 (ko) * 2013-08-22 2015-02-26 가톨릭대학교 산학협력단 다우리놀 화합물을 유효성분으로 포함하는 면역질환의 예방 및 치료용 조성물
KR101606645B1 (ko) 2013-08-22 2016-03-25 가톨릭대학교 산학협력단 다우리놀 화합물을 유효성분으로 포함하는 면역질환의 예방 및 치료용 조성물
CN109394733A (zh) * 2018-12-14 2019-03-01 上海交通大学 一种红细胞膜包封的粉防己碱plga纳米粒及其制备方法及其应用
CN111888356B (zh) * 2020-09-01 2021-07-27 重庆布尔动物药业有限公司 异喹啉类生物碱在制备抗耐药的溶血性葡萄球菌的药物中的应用
CN113750097A (zh) * 2021-10-11 2021-12-07 上海市第十人民医院 Hayatine及其类似物在制备mTORC1抑制剂中的应用
CN115120592A (zh) * 2022-06-28 2022-09-30 傅绍义 缓解皮肤瘙痒和过敏的组合物、临床测试方法及应用
CN115197231B (zh) * 2022-08-15 2023-01-17 北京中医药大学 广谱抗病毒中药单体小檗胺及其应用
WO2024104415A1 (en) * 2022-11-16 2024-05-23 Hangzhou Jianlai Biotechnology Co., Ltd. Bisbenzylisoquinoline compounds as ferroptosis inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2627666B2 (ja) * 1989-07-13 1997-07-09 花王株式会社 抗アレルギー剤
JPH0499723A (ja) * 1990-08-17 1992-03-31 Kaken Shiyouyaku Kk ウイルス・ゲノム不活化剤
EP0536360A4 (en) * 1991-03-05 1993-08-04 Bloom, Leonard Topical treatment of acne
US5627195A (en) * 1995-04-11 1997-05-06 Massachusetts Eye And Ear Infirmary Treatment for ocular inflammation

Also Published As

Publication number Publication date
EP0820286A4 (de) 2000-01-05
EP0820286A1 (de) 1998-01-28
CA2217599A1 (en) 1996-10-17
DE69635708T2 (de) 2006-08-24
US5627195A (en) 1997-05-06
CN1148187C (zh) 2004-05-05
CN1187123A (zh) 1998-07-08
JPH11503736A (ja) 1999-03-30
EP0820286B1 (de) 2006-01-04
ES2250990T3 (es) 2006-04-16
WO1996032108A1 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69500089D1 (de) Behandlung von Geflügel
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE69715631D1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69124293D1 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69404785D1 (de) Vorrichtung zur Behandlung von Oberflächen
DE69421196D1 (de) Vorrichtung zur behandlung von überbiss
DE69619916D1 (de) Vorrichtung zur prophylaktischen Behandlung
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69600983D1 (de) Kapselpräparate zur Behandlung von Pflanzen
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69405711D1 (de) Behandlung von rueckstandsoel
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69521138D1 (de) Behandlung von druckbehältern
DE69614739D1 (de) Pflaster zur Behandlung von Pflanzen
DE69619051D1 (de) Behandlung von Füllstoffen mit Oxasilacycloalkanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee